Evidence map›Paper›PMID 31665779›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.

Se Eun Park, Trevor Toy, Ligia Maria Cruz Espinoza, Ursula Panzner, Ondari D Mogeni, Justin Im, Nimesh Poudyal, Gi Deok Pak, Hyeongwon Seo, Yun Chon and 34 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Observational
  2. COVID-19 Surveillance in Madagascar and Urban Burkina Faso: Addressing Underreporting of Disease Burden Through Integrative Analysis of Diverse Data Streams.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Open forum infectious diseases · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Burden of Typhoid Fever in Sub-Saharan Africa: A Perspective.Research and reports in tropical medicine · 2022
    Review
  17. Article
  18. Article
  19. MDR and XDR typhoid fever-a threat for the current decade?The Pan African medical journal · 2021
    Article
  20. Methodological Considerations for Cost of Illness Studies of Enteric Fever.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 17 institutions in 17 countries.

Se Eun ParkInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Trevor ToyInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ligia Maria Cruz EspinozaInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ursula PanznerInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ondari D MogeniInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Justin ImInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Nimesh PoudyalInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Gi Deok PakInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Hyeongwon SeoInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Yun ChonInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Heidi Schütt-GerowittInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Vittal MogasaleInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Enusa RamaniInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ayan DeyInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Ju Yeong ParkInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Jong-Hoon KimInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Hye Jin SeoInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Hyon Jin JeonInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Andrea HaselbeckInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Keriann Conway RoyGlobal Health Institute, Emory University, Atlanta, Georgia.
William MacWrightGlobal Health Institute, Emory University, Atlanta, Georgia.
Yaw Adu-SarkodieSchool of Public Health, and, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ellis Owusu-DaboInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
Isaac OseiKumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Michael OwusuKumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Raphaël RakotozandrindrainyUniversity of Antananarivo, Madagascar.
Abdramane Bassiahi SouraInstitut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
Leon Parfait KaboreSchiphra Hospital, Ouagadougou, Burkina Faso.
Mekonnen TeferiArmauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
Iruka N OkekeFaculty of Pharmacy, University of Ibadan.
Aderemi KehindeDepartment of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan.
Oluwafemi PopoolaDepartment of Community Medicine, College of Medicine, University of Ibadan.
Jan JacobsDepartment of Microbiology and Immunology, KU Leuven.
Octavie Lunguya MetilaInstitut National de Recherche Biomedicales, Kinshasa.
Christian G MeyerInstitute of Tropical Medicine, Eberhard-Karls University of Tübingen, Germany.
John A CrumpKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Sean EliasJenner Institute, University of Oxford, United Kingdom.
Calman A MaclennanClinical Sciences, Liverpool School of Tropical Medicine.
Christopher M ParryClinical Sciences, Liverpool School of Tropical Medicine.
Stephen BakerOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Eric D MintzNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Robert F BreimanDepartment of Medicine, Cambridge University, United Kingdom.
John D Clemensicddr,b, Dhaka, Bangladesh.
Florian MarksInternational Vaccine Institute, Seoul National University Research Park, Republic of Korea.
International Vaccine Institute · KRKwame Nkrumah University of Science and Technology · GHEmory University · USLiverpool School of Tropical Medicine · GBUniversity of Cambridge · GBUniversity of Ibadan · NGAll Africa Leprosy Tuberculosis and Rehabilitation Training Centre · ETCenters for Disease Control and Prevention · USDuke University · USDuy Tan University · VNInstituut voor Tropische Geneeskunde · BEUniversité Joseph Ki-Zerbo · BFUniversity College Hospital · GBUniversity of Antananarivo · MGUniversity of California, Los Angeles · USUniversity of Kinshasa · CDUniversity of Oxford · GB

Funding

Medical Research Council MR/P008852/1
6 · The paper itself

Abstract

backgroundInvasive salmonellosis is a common community-acquired bacteremia in persons residing in sub-Saharan Africa. However, there is a paucity of data on severe typhoid fever and its associated acute and chronic host immune response and carriage. The Severe Typhoid Fever in Africa (SETA) program, a multicountry surveillance study, aimed to address these research gaps and contribute to the control and prevention of invasive salmonellosis.

methodsA prospective healthcare facility-based surveillance with active screening of enteric fever and clinically suspected severe typhoid fever with complications was performed using a standardized protocol across the study sites in Burkina Faso, the Democratic Republic of Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria. Defined inclusion criteria were used for screening of eligible patients for enrollment into the study. Enrolled patients with confirmed invasive salmonellosis by blood culture or patients with clinically suspected severe typhoid fever with perforation were eligible for clinical follow-up. Asymptomatic neighborhood controls and immediate household contacts of each case were enrolled as a comparison group to assess the level of Salmonella-specific antibodies and shedding patterns. Healthcare utilization surveys were performed to permit adjustment of incidence estimations. Postmortem questionnaires were conducted in medically underserved areas to assess death attributed to invasive Salmonella infections in selected sites.

resultsResearch data generated through SETA aimed to address scientific knowledge gaps concerning the severe typhoid fever and mortality, long-term host immune responses, and bacterial shedding and carriage associated with natural infection by invasive salmonellae.

conclusionsSETA supports public health policy on typhoid immunization strategy in Africa.

Indexed as

AdultAfrica South of the SaharaBacteremiaCarrier StateChild, PreschoolCommunity-Acquired InfectionsHealth Services ResearchHumansIncidenceInfantParentsPatient Acceptance of Health CareProspective StudiesResearch DesignSalmonella InfectionsSurveys and Questionnaireshost immunity and carriageinvasive SalmonellosisSevere typhoid feversub-Saharan Africasurveillance protocol

Identifiers

PMID31665779
PMCPMC6821161
OpenAlexW2982604517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.